MedPath

A randomized, double-blind, cross-over trial of two speech coding strategies in cochlear implantatio

Phase 2
Completed
Conditions
deafness
hard of hearing
10022396
Registration Number
NL-OMON36103
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

-18 years and older
-experience with a cochlear implant for at least six months
- Advanced Bionics Inc. cochlear implant
- Able to participate in fitting and testing session

Exclusion Criteria

No or very poor ability to understand speech with the cochlear implant and it*s current speech processing strategy, as evidenced by a phoneme score <40% in standard speech audiometry.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameters: Improvement of PLS over HiRes for a speech in noise<br /><br>test. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes are: improvement on a speech in quite test, improvement on a<br /><br>frequency discrimination test, improvement on the SSQ questionnaire. </p><br>
© Copyright 2025. All Rights Reserved by MedPath